- Home
- Commercial Insight Antihormonal Cancer Therapies Leading brands strive to minimize generic sales erosion
Commercial Insight Antihormonal Cancer Therapies Leading brands strive to minimize generic sales erosion
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Meat and Poultry in Spain: Liver Failure - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- by Global Markets Direct
- February 2013
- 56 pages
This report provides information on the therapeutic development for Liver Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Failure. 'Liver Failure - Pipeline Review, H1 2012' ...
Industries: Therapy | Countries: Spain, World
Regado Biosciences, Inc. - Product Pipeline Review - 2012
- $ 1 500
- Company report
- by Global Markets Direct
- November 2012
- 34 pages
Regado Biosciences, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Regado Biosciences, Inc. - Product Pipeline Review - 2012? provides data on the Regado Biosciences, Inc.'s research and development focus. The report includes information on current developmental ...
Industries: Therapy | Countries: World, Spain
Treatment Algorithms: Postherpetic Neuralgia - Lyrica forms the cornerstone of treatment for postherpetic neuralgia
- $ 7 600
- Industry report
- by Datamonitor
- November 2012
- 88 pages
Prescribing trends reveal that patients with PHN are typically initiated on monotherapy. Since no single therapy provides sufficient efficacy, physicians increasingly turn to combination therapy at later lines of treatment to optimize patient outcomes. Lyrica (pregabalin; Pfizer) leads the market, with ...
Industries: Therapy | Countries: Spain, United States, United Kingdom, Italy, France, Germany, Japan
Laboratorios Del Dr. Esteve S.A. - Strategic SWOT Analysis Review
- $ 125
- Company report
- by Global Data
- November 2012
- 23 pages
Summary Laboratorios Del Dr. Esteve S.A. (ESTEVE) is a international pharmaceutical company that conducts research and development of new molecules, marketing, development and manufacturing of pharmaceuticals. It focuses its operations in two areas, pharmaceuticals and active pharmaceutical ingredients ...
Industries: Therapy | Countries: United States, Mexico, Sweden, Spain, Italy, Germany, China
Disease and Therapy Review: Crohn%s Disease
- $ 995
- Industry report
- by Timely Data Resources Inc.
- November 2012
- 13 pages
Abstract The Crohn's Disease Disease and Therapy Review provides an overview of the condition, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types and ...
Industries: Therapy | Countries: South Korea, World, Italy, Canada, Japan, Europe, North America, Australia, Singapore, United States, United Kingdom, Spain, France, Germany, China, Asia
Disease and Therapy Review: Melanoma
- $ 995
- Industry report
- by Timely Data Resources Inc.
- November 2012
- 14 pages
Abstract The Melanoma Disease and Therapy Review provides an overview of skin cancer, with incidence, prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview of treatment by stage and type. Dosing and treatment cost information is provided for various ...
Industries: Therapy | Countries: Russian Federation, World, Philippines, Argentina, South Africa, Europe, Brazil, Mexico, Canada, Sweden, Spain, Poland, Italy, Greece, France, Germany, Thailand, South Korea, Japan, India, China, Egypt, Asia, Africa, United States, United Kingdom, South America, North America
Disease and Therapy Review: Lung Cancer
- $ 995
- Industry report
- by Timely Data Resources Inc.
- November 2012
- 15 pages
Abstract The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, ...
Industries: Therapy | Countries: World, Russian Federation, Europe, Philippines, Argentina, South Africa, Brazil, Mexico, Canada, Spain, Poland, Italy, Greece, France, Germany, Thailand, Japan, India, China, Egypt, Asia, Africa, United States, United Kingdom, South America, Australia, Sweden, South Korea, North America
Disease and Therapy Review: Overactive Bladder
- $ 995
- Industry report
- by Timely Data Resources Inc.
- November 2012
- 11 pages
Abstract The Overactive Bladder Disease and Therapy Review provides an overview of the condition, withprevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types and for medication. ...
Industries: Therapy | Countries: World, Europe, Spain, Italy, France, Germany, South Korea, Japan, United States, United Kingdom
Disease and Therapy Review: Multiple Sclerosis
- $ 995
- Industry report
- by Timely Data Resources Inc.
- November 2012
- 15 pages
Abstract The Multiple Sclerosis Disease and Therapy Review provides and overview of the disease and its types, global patterns and incidence and prevalence numbers for major countries worldwide. Information on treatment is provided, as well as treatment and dosing costs of MS drugs. General information ...
Industries: Therapy | Countries: World, Europe, Spain, Italy, France, Denmark, Taiwan, United States, Canada, United Kingdom, Germany, Japan, India, China, Asia, Africa
Acute Lymphocytic Leukemia Therapeutics Market (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)
- $ 4 650
- Industry report
- by MarketsandMarkets
- November 2012
- 118 pages
The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, ...
Industries: Therapy | Countries: France, Canada, Spain, Italy, Germany, Japan, Europe, World, North America
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- (866) 682 9815
ref:plp2010
Reportlinker.com © Copyright 2013. All rights reserved.
